Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

DS Healthcare Group Inc prepares to file investigational new drug application with FDA


Thursday, 9 Jan 2014 08:00am EST 

DS Healthcare Group Inc:Says it is preparing to submit to the United States Food and Drug Administration (FDA) an Investigational New Drug Application (IND) for its topical hair loss treatment. 

Company Quote

1.56
0.05 +3.31%
9 Jul 2014